Henry Schein Inc (BSP:H1SI34)
R$ 180.72 0 (0%) Market Cap: 46.28 Bil Enterprise Value: 66.83 Bil PE Ratio: 24.15 PB Ratio: 2.56 GF Score: 89/100

Henry Schein Inc at UBS Global Healthcare Conference Transcript

May 24, 2022 / 06:00PM GMT
Release Date Price: R$200.4
Kevin Caliendo
UBS Investment Bank, Research Division - Equity Research Analyst of Healthcare IT and Distribution

Good afternoon, everybody. Thanks for joining us for day 2, the UBS Healthcare Conference. We are very proud today to have management from Henry Schein. With us is Ron South, new CFO; and Graham Stanley. That's an easy one to remember. And Graham Stanley, who's Head of IR. Thank you so much, gentlemen. Thanks for attending today.

Questions & Answers

Kevin Caliendo
UBS Investment Bank, Research Division - Equity Research Analyst of Healthcare IT and Distribution

Ron, I want to start off. This is, I believe, your first official conference, right, meeting investors sort of this kind of venue. And you've been in the role now for a few months. Take us through sort of the process, how is it going? Is it everything you always dreamed it would be?

Ronald N. South
Henry Schein, Inc. - Senior VP & CFO

Well, I think some of you may have met at some point in time, Steve Paladino. Steve was my

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot